Herbert Yu
Impact in
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Growth Hormone and Insulin-like Growth Factors
Papers in
-
- Metabolism, Diabetes, and Cancer 22
- RNA modifications and cancer 20
- Epigenetics and DNA Methylation 17
- Oncology 57
- Cancer Risks and Factors 25
- Pancreatic and Hepatic Oncology Research 13
- Co-authors
- Lingeng Lu (44 shared papers)Dionyssios Katsaros (47 shared papers)Biyun Qian (42 shared papers)Harvey A. Risch (35 shared papers)Melinda L. Irwin (16 shared papers)Irene A. Rigault de la Longrais (14 shared papers)Xiaomei Ma (5 shared papers)Thomas Rutherford (13 shared papers)
- Journals
- Cancer Research (16 papers)Breast Cancer Research and Treatment (13 papers)Cancer Epidemiology Biomarkers & Prevention (12 papers)Scientific Reports (8 papers)Oncotarget (8 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Herbert Yu
256 papers receiving 12.3k citations
Herbert Yu's Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 3.1k
- Endocrinology, Diabetes and Metabolism 1.8k
- Oncology 2.8k
- Obstetrics and Gynecology 513
- Molecular Biology 5.1k
Countries citing papers authored by Herbert Yu
This map shows the geographic impact of Herbert Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Yu more than expected).
Fields of papers citing papers by Herbert Yu
This network shows the impact of papers produced by Herbert Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Yu. The network helps show where Herbert Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Herbert Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 259 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression Hit paper breakdown → | 2000 | 1214 |
| 2 | A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53 Hit paper breakdown → | 2018 | 415 |
| 3 | 2008 | 332 | |
| 4 | 2007 | 255 | |
| 5 | 2004 | 253 | |
| 6 | Global burden of cancer. | 2006 | 232 |
| 7 | 2008 | 226 | |
| 8 | 2008 | 224 | |
| 9 | 2009 | 212 | |
| 10 | 2008 | 183 | |
| 11 | 2018 | 165 | |
| 12 | 2005 | 162 | |
| 13 | 1999 | 159 | |
| 14 | Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. | 1995 | 157 |
| 15 | 2012 | 156 | |
| 16 | 2009 | 155 | |
| 17 | 2009 | 143 | |
| 18 | 2015 | 127 | |
| 19 | 2010 | 123 | |
| 20 | 2001 | 121 |
About Herbert Yu
Herbert Yu is a scholar working on Molecular Biology, Oncology, Cancer Research, Endocrinology, Diabetes and Metabolism and Genetics, having authored 259 papers that have together received 12.6k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (41 papers), Cancer-related molecular mechanisms research (28 papers), Cancer Risks and Factors (25 papers), Metabolism, Diabetes, and Cancer (22 papers), RNA modifications and cancer (20 papers), Epigenetics and DNA Methylation (17 papers), Endometrial and Cervical Cancer Treatments (14 papers) and Pancreatic and Hepatic Oncology Research (13 papers). The work is most often cited by research in Cancer Research (3.1k citations), Endocrinology, Diabetes and Metabolism (1.8k citations), Oncology (2.8k citations), Obstetrics and Gynecology (513 citations) and Molecular Biology (5.1k citations). Herbert Yu has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Lingeng Lu, Dionyssios Katsaros, Biyun Qian, Harvey A. Risch, Melinda L. Irwin, Irene A. Rigault de la Longrais, Xiaomei Ma, Thomas Rutherford, Hans J. Berkel and Susan T. Mayne. Their work appears in journals such as Cancer Research, Breast Cancer Research and Treatment, Cancer Epidemiology Biomarkers & Prevention, Scientific Reports and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.